{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T04:14:28Z","timestamp":1746591268340,"version":"3.40.5"},"publisher-location":"New York, NY","reference-count":48,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071644331"},{"type":"electronic","value":"9781071644348"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4434-8_4","type":"book-chapter","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T11:12:49Z","timestamp":1746011569000},"page":"51-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BioID-Based Proximity Mapping of Transmembrane Proteins in Human Airway Cell Models"],"prefix":"10.1007","author":[{"given":"Melissa","family":"Iazzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Astori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"St-Germain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Raught","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gagan D.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/ijms24010468","volume":"24","author":"M Jelokhani-Niaraki","year":"2022","unstructured":"Jelokhani-Niaraki M (2022) Membrane proteins: structure, function and motion. Int J Mol Sci 24:468","journal-title":"Int J Mol Sci"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1042\/BST20160025","volume":"44","author":"AE Rawlings","year":"2016","unstructured":"Rawlings AE (2016) Membrane proteins: always an insoluble problem? Biochem Soc Trans 44:790\u2013795","journal-title":"Biochem Soc Trans"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1038\/nprot.2016.140","volume":"11","author":"S Pankow","year":"2016","unstructured":"Pankow S, Bamberger C, Calzolari D, Bamberger A, Yates JR (2016) Deep interactome profiling of membrane proteins by co-interacting protein identification technology. Nat Protoc 11:2515\u20132528","journal-title":"Nat Protoc"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1021\/bi301604j","volume":"52","author":"KL Schey","year":"2013","unstructured":"Schey KL, Grey AC, Nicklay JJ (2013) Mass spectrometry of membrane proteins: a focus on Aquaporins. Biochemistry 52:3807\u20133817","journal-title":"Biochemistry"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/pmic.200900258","volume":"10","author":"L Fagerberg","year":"2010","unstructured":"Fagerberg L, Jonasson K, von Heijne G, Uhl\u00e9n M, Berglund L (2010) Prediction of the human membrane proteome. Proteomics 10:1141\u20131149","journal-title":"Proteomics"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.tips.2021.05.006","volume":"42","author":"E Gulezian","year":"2021","unstructured":"Gulezian E et al (2021) Membrane protein production and formulation for drug discovery. Trends Pharmacol Sci 42:657\u2013674","journal-title":"Trends Pharmacol Sci"},{"issue":"15","key":"4_CR7","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14928","volume":"9","author":"KA Cottrill","year":"2021","unstructured":"Cottrill KA et al (2021) Sphingomyelinase decreases transepithelial anion secretion in airway epithelial cells in part by inhibiting CFTR-mediated apical conductance. Physiol Rep 9(15):e14928","journal-title":"Physiol Rep"},{"key":"4_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112717","volume":"206","author":"C Costantini","year":"2020","unstructured":"Costantini C et al (2020) Selectively targeting key inflammatory pathways in cystic fibrosis. Eur J Med Chem 206:112717","journal-title":"Eur J Med Chem"},{"key":"4_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2021.102098","volume":"72","author":"O Laselva","year":"2022","unstructured":"Laselva O et al (2022) Small-molecule drugs for cystic fibrosis: where are we now? Pulm Pharmacol Ther 72:102098","journal-title":"Pulm Pharmacol Ther"},{"key":"4_CR10","first-page":"59","volume":"2","author":"M Mergiotti","year":"2022","unstructured":"Mergiotti M, Murabito A, Prono G, Ghigo A (2022) CFTR modulator therapy for rare CFTR mutants. J Resp 2:59\u201376","journal-title":"J Resp"},{"key":"4_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00275","volume":"7","author":"M Lopes-Pacheco","year":"2016","unstructured":"Lopes-Pacheco M (2016) CFTR modulators: shedding light on precision medicine for cystic fibrosis. Front Pharmacol 7:275","journal-title":"Front Pharmacol"},{"key":"4_CR12","doi-asserted-by":"publisher","unstructured":"Iazzi M et al (2023) Synthesis and evaluation of Ivacaftor derivatives with reduced lipophilicity. ACS Omega. https:\/\/doi.org\/10.1021\/acsomega.3c05839","DOI":"10.1021\/acsomega.3c05839"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"18843","DOI":"10.1073\/pnas.1105787108","volume":"108","author":"F Van Goor","year":"2011","unstructured":"Van Goor F et al (2011) Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci 108:18843\u201318848","journal-title":"Proc Natl Acad Sci"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cell.2019.12.032","volume":"180","author":"CE Bear","year":"2020","unstructured":"Bear CE (2020) A therapy for most with cystic fibrosis. Cell 180:211. Preprint at https:\/\/doi.org\/10.1016\/j.cell.2019.12.032","journal-title":"Cell"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1001\/jama.2017.16823","volume":"318","author":"GR Cutting","year":"2017","unstructured":"Cutting GR (2017) Treating specific variants causing cystic fibrosis. JAMA 318:2130","journal-title":"JAMA"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"2002774","DOI":"10.1183\/13993003.02774-2020","volume":"57","author":"O Laselva","year":"2021","unstructured":"Laselva O et al (2021) Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator. Eur Respir J 57:2002774","journal-title":"Eur Respir J"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/genes12081178","volume":"12","author":"V Terlizzi","year":"2021","unstructured":"Terlizzi V et al (2021) Effectiveness of Elexacaftor\/Tezacaftor\/Ivacaftor therapy in three subjects with the cystic fibrosis genotype Phe508del\/unknown and advanced lung disease. Genes (Basel) 12:1178","journal-title":"Genes (Basel)"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1056\/NEJMoa1409547","volume":"373","author":"CE Wainwright","year":"2015","unstructured":"Wainwright CE et al (2015) Lumacaftor\u2013ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. N Engl J Med 373:220\u2013231","journal-title":"N Engl J Med"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"17640","DOI":"10.1038\/s41598-019-54158-2","volume":"9","author":"P-W Phuan","year":"2019","unstructured":"Phuan P-W et al (2019) Nanomolar-potency \u2018co-potentiator\u2019 therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants. Sci Rep 9:17640","journal-title":"Sci Rep"},{"key":"4_CR20","volume-title":"Who KALYDECO\u00ae Is For","author":"Vertex Pharmaceuticals Incorporated","year":"2023","unstructured":"Vertex Pharmaceuticals Incorporated (2023) Who KALYDECO\u00ae Is For"},{"issue":"18","key":"4_CR21","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139983","volume":"5","author":"G Veit","year":"2020","unstructured":"Veit G et al (2020) Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination. JCI Insight 5(18):e139983","journal-title":"JCI Insight"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.3390\/ijms241411457","volume":"24","author":"M Iazzi","year":"2023","unstructured":"Iazzi M, Sadeghi S, Gupta GD (2023) A proteomic survey of the cystic fibrosis transmembrane conductance regulator Surfaceome. Int J Mol Sci 24:11457","journal-title":"Int J Mol Sci"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.3390\/ijms23052442","volume":"23","author":"M Iazzi","year":"2022","unstructured":"Iazzi M, Astori A, St-Germain J, Raught B, Gupta GD (2022) Proximity profiling of the CFTR interaction landscape in response to Orkambi. Int J Mol Sci 23:2442","journal-title":"Int J Mol Sci"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nature15729","volume":"528","author":"S Pankow","year":"2015","unstructured":"Pankow S et al (2015) \u0394F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. Nature 528:510\u2013516","journal-title":"Nature"},{"issue":"16","key":"4_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168937","volume":"23","author":"B Chevalier","year":"2022","unstructured":"Chevalier B et al (2022) Differential CFTR-Interactome proximity labeling procedures identify enrichment in multiple SLC transporters. Int J Mol Sci 23(16):8937","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4_CR26","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202110629","volume":"18","author":"SH Lim","year":"2022","unstructured":"Lim SH et al (2022) CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system. Mol Syst Biol 18(2):e10629","journal-title":"Mol Syst Biol"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1016\/j.jmb.2018.06.017","volume":"430","author":"DM Hutt","year":"2018","unstructured":"Hutt DM, Loguercio S, Campos AR, Balch WE (2018) A proteomic variant approach (ProVarA) for personalized medicine of inherited and somatic disease. J Mol Biol 430:2951\u20132973","journal-title":"J Mol Biol"},{"issue":"7","key":"4_CR28","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E21-11-0578","volume":"33","author":"EF McDonald","year":"2022","unstructured":"McDonald EF, Sabusap CMP, Kim M, Plate L (2022) Distinct proteostasis states drive pharmacologic chaperone susceptibility for cystic fibrosis transmembrane conductance regulator misfolding mutants. Mol Biol Cell 33(7):ar62","journal-title":"Mol Biol Cell"},{"issue":"1","key":"4_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06588-z","volume":"7","author":"R Reilly","year":"2017","unstructured":"Reilly R et al (2017) Targeting the PI3K\/Akt\/mTOR signalling pathway in cystic fibrosis. Sci Rep 7(1):7642","journal-title":"Sci Rep"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s42003-020-0909-1","volume":"3","author":"KA Cottrill","year":"2020","unstructured":"Cottrill KA, Farinha CM, McCarty NA (2020) The bidirectional relationship between CFTR and lipids. Commun Biol 3:179","journal-title":"Commun Biol"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1038\/nprot.2013.129","volume":"8","author":"N Das","year":"2013","unstructured":"Das N, Murray DT, Cross TA (2013) Lipid bilayer preparations of membrane proteins for oriented and magic-angle spinning solid-state NMR samples. Nat Protoc 8:2256\u20132270","journal-title":"Nat Protoc"},{"key":"4_CR32","first-page":"19.23.1","volume":"91","author":"KJ Roux","year":"2018","unstructured":"Roux KJ, Kim DI, Burke B, May DG (2018) BioID: a screen for protein-protein interactions. Curr Protoc Protein Sci 91:19.23.1\u201319.23.15","journal-title":"Curr Protoc Protein Sci"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-1-0716-3507-0_11","volume":"2725","author":"M Iazzi","year":"2024","unstructured":"Iazzi M, St-Germain J, Acharya S, Raught B, Gupta GD (2024) Proximity mapping of ciliary proteins by BioID. Methods Mol Biol 2725:181\u2013198. https:\/\/doi.org\/10.1007\/978-1-0716-3507-0_11","journal-title":"Methods Mol Biol"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1083\/jcb.201112098","volume":"196","author":"KJ Roux","year":"2012","unstructured":"Roux KJ, Kim DI, Raida M, Burke B (2012) A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J Cell Biol 196:801\u2013810","journal-title":"J Cell Biol"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cbpa.2018.10.017","volume":"48","author":"AC Gingras","year":"2019","unstructured":"Gingras AC, Abe KT, Raught B (2019) Getting to know the neighborhood: using proximity-dependent biotinylation to characterize protein complexes and map organelles. Curr Opin Chem Biol 48:44\u201354","journal-title":"Curr Opin Chem Biol"},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.cell.2015.10.065","volume":"163","author":"GD Gupta","year":"2015","unstructured":"Gupta GD et al (2015) A dynamic protein interaction landscape of the human centrosome-cilium Interface. Cell 163:1484\u20131499","journal-title":"Cell"},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1074\/mcp.TIR118.000902","volume":"17","author":"P Samavarchi-Tehrani","year":"2018","unstructured":"Samavarchi-Tehrani P, Abdouni H, Samson R, Gingras A-C (2018) A versatile lentiviral delivery toolkit for proximity-dependent Biotinylation in diverse cell types. Mol Cell Proteomics 17:2256\u20132269","journal-title":"Mol Cell Proteomics"},{"key":"4_CR38","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1159\/000335765","volume":"28","author":"J Ousingsawat","year":"2011","unstructured":"Ousingsawat J, Kongsuphol P, Schreiber R, Kunzelmann K (2011) CFTR and TMEM16A are separate but functionally related Cl\u2212 channels. Cell Physiol Biochem 28:715\u2013724","journal-title":"Cell Physiol Biochem"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"2000111","DOI":"10.1002\/anbr.202000111","volume":"1","author":"D Baldassi","year":"2021","unstructured":"Baldassi D, Gabold B, Merkel OM (2021) Air\u2212liquid Interface cultures of the healthy and diseased human respiratory tract: promises, challenges, and future directions. Adv Nanobiomed Res 1:2000111","journal-title":"Adv Nanobiomed Res"},{"key":"4_CR40","first-page":"637","volume":"94","author":"A Enemark","year":"2021","unstructured":"Enemark A, J\u00f6nsson \u00c5LM, Kronborg-White S, Bendstrup E (2021) Pulmonary alveolar Microlithiasis \u2013 a review. Yale J Biol Med 94:637\u2013644","journal-title":"Yale J Biol Med"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8247935","volume":"2018","author":"B Connolly","year":"2018","unstructured":"Connolly B, Isaacs C, Cheng L, Asrani KH, Subramanian RR (2018) SERPINA1 mRNA as a treatment for Alpha-1 antitrypsin deficiency. J Nucleic Acids 2018:1\u20137","journal-title":"J Nucleic Acids"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.gene.2015.02.038","volume":"561","author":"A John","year":"2015","unstructured":"John A, Kizhakkedath P, Al-Gazali L, Ali BR (2015) Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension. Gene 561:148\u2013156","journal-title":"Gene"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/B978-0-12-385015-7.00017-X","volume-title":"Biotechnology","author":"DP Clark","year":"2016","unstructured":"Clark DP, Pazdernik NJ (2016) Inherited defects and gene therapy. In: Biotechnology. Elsevier, pp 523\u2013564. https:\/\/doi.org\/10.1016\/B978-0-12-385015-7.00017-X"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nmeth.4330","volume":"14","author":"JDR Knight","year":"2017","unstructured":"Knight JDR et al (2017) ProHits-viz: a suite of web tools for visualizing interaction proteomics data. Nat Methods 14:645\u2013646","journal-title":"Nat Methods"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/gm404","volume":"4","author":"RJ Louie","year":"2012","unstructured":"Louie RJ et al (2012) A yeast phenomic model for the gene interaction network modulating CFTR-\u0394F508 protein biogenesis. Genome Med 4:103","journal-title":"Genome Med"},{"key":"4_CR46","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.37018","volume":"7","author":"MJ Shurtleff","year":"2018","unstructured":"Shurtleff MJ et al (2018) The ER membrane protein complex interacts cotranslationally to enable biogenesis of multipass membrane proteins. elife 7:e37018","journal-title":"elife"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1091\/mbc.E20-11-0688","volume":"32","author":"L He","year":"2021","unstructured":"He L et al (2021) DNAJB12 and Hsp70 triage arrested intermediates of N1303K-CFTR for endoplasmic reticulum-associated autophagy. Mol Biol Cell 32:538\u2013553","journal-title":"Mol Biol Cell"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.ygeno.2019.06.028","volume":"112","author":"PT Ikpa","year":"2020","unstructured":"Ikpa PT et al (2020) Transcriptome analysis of the distal small intestine of Cftr null mice. Genomics 112:1139\u20131150","journal-title":"Genomics"}],"container-title":["Methods in Molecular Biology","The Surfaceome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4434-8_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:29:13Z","timestamp":1746520153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4434-8_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071644331","9781071644348"],"references-count":48,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4434-8_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"1 May 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}